HEADER HYDROLASE 14-JUN-12 4FLG TITLE HIV-1 PROTEASE MUTANT I47V COMPLEXED WITH REACTION INTERMEDIATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 PROTEASE; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: PR, RETROPEPSIN; COMPND 5 EC: 3.4.23.16; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HIV-1 PROTEASE, FRAGMENT; COMPND 10 CHAIN: C; COMPND 11 FRAGMENT: SEE REMARK 999; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HIV-1 PROTEASE, FRAGMENT; COMPND 15 CHAIN: E; COMPND 16 FRAGMENT: SEE REMARK 999; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: HIV-1 PROTEASE, FRAGMENT; COMPND 20 CHAIN: F; COMPND 21 FRAGMENT: SEE REMARK 999; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11676; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 9 ORGANISM_COMMON: HIV-1; SOURCE 10 ORGANISM_TAXID: 11676; SOURCE 11 GENE: GAG-POL; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET11A; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 19 ORGANISM_COMMON: HIV-1; SOURCE 20 ORGANISM_TAXID: 11676; SOURCE 21 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 23 MOL_ID: 4; SOURCE 24 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 25 ORGANISM_COMMON: HIV-1; SOURCE 26 ORGANISM_TAXID: 11676; SOURCE 27 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS HYDROLASE, CATALYTIC MECHANISM, DRUG RESISTANCE, ASPARTIC PROTEASE EXPDTA X-RAY DIFFRACTION AUTHOR X.YU,C.H.SHEN,I.T.WEBER REVDAT 2 28-NOV-12 4FLG 1 COMPND DBREF REMARK SEQRES REVDAT 1 17-OCT-12 4FLG 0 JRNL AUTH C.H.SHEN,Y.TIE,X.YU,Y.F.WANG,A.Y.KOVALEVSKY,R.W.HARRISON, JRNL AUTH 2 I.T.WEBER JRNL TITL CAPTURING THE REACTION PATHWAY IN NEAR-ATOMIC-RESOLUTION JRNL TITL 2 CRYSTAL STRUCTURES OF HIV-1 PROTEASE. JRNL REF BIOCHEMISTRY V. 51 7726 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 22963370 JRNL DOI 10.1021/BI3008092 REMARK 2 REMARK 2 RESOLUTION. 1.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.146 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.180 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2796 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 55879 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.129 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.127 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.162 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2259 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 53083 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1581 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 184 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1732.40 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1641.88 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 25 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 16870 REMARK 3 NUMBER OF RESTRAINTS : 21928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.031 REMARK 3 ANGLE DISTANCES (A) : 0.039 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.038 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.067 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.069 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.121 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.039 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.096 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NO CUTOFF FOR ANISOTROPIC REFINEMENT REMARK 4 REMARK 4 4FLG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JUN-12. REMARK 100 THE RCSB ID CODE IS RCSB073046. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : SI220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53227 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.310 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.60100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1FG6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M SODIUM ACETATE BUFFER, 1.2 M REMARK 280 SODIUM FORMATE, AND 2.5% PEG8000, PH 5.0, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.04000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.04000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, C, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP C 260 CG OD1 OD2 REMARK 470 GLN C 261 CG CD OE1 NE2 REMARK 470 GLN E 361 CG CD OE1 NE2 REMARK 470 ILE F 366 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 41 CD - NE - CZ ANGL. DEV. = 9.6 DEGREES REMARK 500 ARG B 41 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG B 57 CD - NE - CZ ANGL. DEV. = 9.9 DEGREES REMARK 500 ARG B 57 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A 57 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 744 DISTANCE = 6.84 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 102 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 740 O REMARK 620 2 ASP B 60 O 102.6 REMARK 620 3 HOH B 741 O 157.9 98.6 REMARK 620 4 HOH B 726 O 103.6 78.2 86.5 REMARK 620 5 HOH B 719 O 76.7 96.6 95.1 174.8 REMARK 620 6 HOH B 736 O 84.2 172.9 74.8 98.5 86.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLU B 100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ILE B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 103 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3B7V RELATED DB: PDB REMARK 900 RELATED ID: 3B80 RELATED DB: PDB REMARK 900 RELATED ID: 4FL8 RELATED DB: PDB REMARK 900 RELATED ID: 4FM6 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 AUTHOR STATES THAT CHAIN C, E AND F ARE SELF PROTEOLYTIC PRODUCT OF REMARK 999 HIV-1 PROTEASE. SEQUENCE OF CHAIN C (DQII), CHAIN E (QIII), CHAIN F REMARK 999 (IEI), residues GLU B100 and ILE B101, CORRESPOND TO RESIDUES 60- REMARK 999 63, 61-63, 64-66, 64 and 65 OF HIV-1 PROTEASE RESPECTIVELY. DBREF 4FLG B 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 4FLG A 1 99 UNP P03367 POL_HV1BR 501 599 DBREF 4FLG C 260 263 UNP P03367 POL_HV1BR 560 563 DBREF 4FLG E 361 363 UNP P03367 POL_HV1BR 561 563 DBREF 4FLG F 364 366 UNP P03367 POL_HV1BR 564 566 SEQADV 4FLG LYS B 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 4FLG ILE B 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 4FLG VAL B 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 4FLG ILE B 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 4FLG ALA B 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 4FLG ALA B 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQADV 4FLG LYS A 7 UNP P03367 GLN 507 ENGINEERED MUTATION SEQADV 4FLG ILE A 33 UNP P03367 LEU 533 ENGINEERED MUTATION SEQADV 4FLG VAL A 47 UNP P03367 ILE 547 ENGINEERED MUTATION SEQADV 4FLG ILE A 63 UNP P03367 LEU 563 ENGINEERED MUTATION SEQADV 4FLG ALA A 67 UNP P03367 CYS 567 ENGINEERED MUTATION SEQADV 4FLG ALA A 95 UNP P03367 CYS 595 ENGINEERED MUTATION SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET VAL GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 C 4 ASP GLN ILE ILE SEQRES 1 E 3 GLN ILE ILE SEQRES 1 F 3 ILE GLU ILE HET GLU B 100 9 HET ILE B 101 8 HET NA B 102 1 HET CL B 103 1 HET CL B 104 1 HET CL B 105 1 HET CL A 101 1 HET GOL A 102 6 HET GOL A 103 6 HETNAM GLU GLUTAMIC ACID HETNAM ILE ISOLEUCINE HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 6 GLU C5 H9 N O4 FORMUL 7 ILE C6 H13 N O2 FORMUL 8 NA NA 1+ FORMUL 9 CL 4(CL 1-) FORMUL 13 GOL 2(C3 H8 O3) FORMUL 15 HOH *184(H2 O) HELIX 1 1 GLY B 86 THR B 91 1 6 HELIX 2 2 GLN B 92 GLY B 94 5 3 HELIX 3 3 GLY A 86 THR A 91 1 6 SHEET 1 A 4 GLN B 2 ILE B 3 0 SHEET 2 A 4 THR A 96 ASN A 98 -1 O LEU A 97 N ILE B 3 SHEET 3 A 4 THR B 96 ASN B 98 -1 N ASN B 98 O THR A 96 SHEET 4 A 4 GLN A 2 ILE A 3 -1 O ILE A 3 N LEU B 97 SHEET 1 B 8 LYS B 43 GLY B 49 0 SHEET 2 B 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 B 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 B 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 B 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 B 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 B 8 LEU B 10 ILE B 15 -1 N ILE B 13 O LYS B 20 SHEET 8 B 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 C 8 LYS A 43 GLY A 49 0 SHEET 2 C 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 C 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 C 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 C 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 C 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 C 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 C 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 D 2 GLN C 261 ILE C 262 0 SHEET 2 D 2 GLU F 365 ILE F 366 -1 O ILE F 366 N GLN C 261 LINK NA NA B 102 O HOH B 740 1555 1555 2.23 LINK O ASP B 60 NA NA B 102 1555 1555 2.30 LINK NA NA B 102 O HOH B 741 1555 1555 2.34 LINK NA NA B 102 O HOH B 726 1555 1555 2.37 LINK NA NA B 102 O HOH B 719 1555 1555 2.55 LINK NA NA B 102 O HOH B 736 1555 1555 2.92 LINK N AGLU B 100 C AILE B 101 1555 1555 1.33 SITE 1 AC1 8 GLY B 27 ALA B 28 ASP B 29 ASP B 30 SITE 2 AC1 8 VAL B 47 GLY B 48 ILE B 101 HOH B 738 SITE 1 AC2 9 LEU A 23 ASP A 25 ILE A 84 GLY B 27 SITE 2 AC2 9 GLY B 49 GLU B 100 ILE C 263 ILE F 364 SITE 3 AC2 9 HOH F 401 SITE 1 AC3 6 ASP B 60 HOH B 719 HOH B 726 HOH B 736 SITE 2 AC3 6 HOH B 740 HOH B 741 SITE 1 AC4 2 ARG B 41 TRP B 42 SITE 1 AC5 2 GLY B 16 GLY B 17 SITE 1 AC6 4 THR A 4 LEU A 5 ALA B 95 HOH B 706 SITE 1 AC7 3 GLN A 2 ILE A 3 THR A 4 SITE 1 AC8 5 PRO A 1 ILE A 3 VAL A 11 HOH A 215 SITE 2 AC8 5 HOH A 285 SITE 1 AC9 7 THR A 12 GLU A 65 ALA A 67 GLY A 68 SITE 2 AC9 7 GLN B 18 MET B 36 SER B 37 CRYST1 58.080 86.300 46.350 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017218 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011587 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021575 0.00000 MASTER 285 0 9 3 22 0 15 6 0 0 0 19 END